Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

FLGT

Fulgent Genetics Inc

Mar 04 • 04:00PM ET

13.99

+0.20 1.45 %

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN QGEN EXAS GH CDNA TXG ONC VCYT MYGN OMIC

| Held by: VTI IWM VXF FNDA VTWO IWN IBB VHT DFAS SCHA

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.97	Insider Own	35.33%	Shs Outstand	31.08M	Perf Week	-40.62%
Market Cap	436.92M	Forward P/E	-	EPS next Y	-1.48	Insider Trans	-0.14%	Shs Float	20.20M	Perf Month	-46.44%
Enterprise Value	103.61M	PEG	-	EPS next Q	-0.39	Inst Own	57.51%	Short Float	7.66%	Perf Quarter	-50.95%
Income	-60.51M	P/S	1.35	EPS this Y	-434.92%	Inst Trans	3.33%	Short Ratio	5.24	Perf Half Y	-37.29%
Sales	322.67M	P/B	0.39	EPS next Y	-5.56%	ROA	-4.90%	Short Interest	1.55M	Perf YTD	-46.75%
Book/sh	35.78	P/C	1.30	EPS next 5Y	-	ROE	-5.39%	52W High	31.04 -54.93%	Perf Year	-9.86%
Cash/sh	10.76	P/FCF	-	EPS past 3/5Y	- -	ROIC	-5.41%	52W Low	13.46 3.94%	Perf 3Y	-58.54%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-19.52% -5.21%	Gross Margin	38.07%	Volatility	9.85% 4.99%	Perf 5Y	-83.64%
Dividend TTM	-	EV/Sales	0.32	EPS Y/Y TTM	-38.87%	Oper. Margin	-28.23%	ATR (14)	1.32	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	6.48	Sales Y/Y TTM	13.83%	Profit Margin	-18.75%	RSI (14)	16.76	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	6.48	EPS Q/Q	-293.49%	SMA20	-35.41%	Beta	0.96	Target Price	24.33
Payout	-	Debt/Eq	0.01	Sales Q/Q	9.34%	SMA50	-43.95%	Rel Volume	2.45	Prev Close	13.79
Employees	1344	LT Debt/Eq	0.01	Earnings	Feb 27 BMO	SMA200	-39.54%	Avg Volume	295.19K	Price	13.99
IPO	Sep 29, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	436.91% -2.39%	Trades		Volume	722,506	Change	1.45%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-05-25	Upgrade	UBS	Neutral → Buy	$30
Dec-07-23	Initiated	UBS	Neutral	$35
Dec-08-22	Downgrade	Piper Sandler	Overweight → Neutral	$65 → $40
Nov-18-22	Initiated	Raymond James	Outperform	$45
Aug-25-22	Initiated	Credit Suisse	Outperform	$65
Feb-04-22	Resumed	Piper Sandler	Overweight	$80
Aug-05-21	Resumed	Credit Suisse	Underperform	$55
Jan-08-21	Downgrade	Credit Suisse	Neutral → Underperform	$42 → $40
Nov-24-20	Downgrade	BTIG Research	Buy → Neutral
Aug-20-20	Initiated	Oppenheimer	Outperform	$75
May-29-20	Initiated	BTIG Research	Buy	$20
Nov-05-19	Upgrade	Piper Jaffray	Neutral → Overweight
Mar-01-18	Downgrade	Piper Jaffray	Overweight → Neutral
Nov-07-17	Downgrade	Raymond James	Outperform → Mkt Perform

Show Previous Ratings

Feb-27-26 04:05PM	Fulgent Genetics Inc (FLGT) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges (GuruFocus.com) -38.09% -7.37%
11:47AM	Fulgent Genetics Q4 Earnings Call Highlights (MarketBeat)
08:15AM	Fulgent Genetics, Inc. (FLGT) Q4 Earnings Top Estimates (Zacks)
07:00AM	Fulgent Reports Fourth Quarter and Full Year 2025 Financial Results (Business Wire)
Feb-24-26 08:11AM	Cheniere Energy to Report Q4 Earnings: What's in the Offing? (Zacks)
07:30AM	Loading…
Feb-12-26 07:30AM	Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026 (Business Wire)
Feb-05-26 05:15PM	Doximity (DOCS) Q3 Earnings and Revenues Surpass Estimates (Zacks) -7.13%
Jan-12-26 05:55AM	New Strong Buy Stocks for January 12th (Zacks)
Dec-23-25 12:35PM	FLGT to Acquire Bako & StrataDx Assets to Expand Pathology Platform (Zacks)
02:12AM	Fulgent Genetics to buy Bako Diagnostics assets and StrataDx (Medical Device Network)
Dec-22-25 04:10PM	Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx (Business Wire)
Nov-08-25 02:05AM	Fulgent Genetics Inc (FLGT) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Upward ... (GuruFocus.com)
Nov-07-25 04:05PM	Fulgent to Participate in Upcoming Conferences (Business Wire) +18.15%
08:20AM	Fulgent Genetics, Inc. (FLGT) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
07:05AM	Fulgent Reports Third Quarter 2025 Financial Results (Business Wire)
06:35PM	Loading…
Nov-06-25 06:35PM	Evolent Health (EVH) Misses Q3 Earnings Estimates (Zacks)
Oct-21-25 07:05AM	Strength Seen in Schrodinger (SDGR): Can Its 13.8% Jump Turn into More Strength? (Zacks)
Oct-20-25 06:00AM	Fulgent Shares Preliminary Data from Poster Presentation at ESMO 2025 Conference (Business Wire) +5.11%
Oct-16-25 07:00AM	Fulgent to Announce Third Quarter 2025 Financial Results on Friday, November 7, 2025 (Business Wire)
Sep-11-25 07:00PM	Fulgent Genetics: A Risky Bet or a Hidden Gem? (Motley Fool)
Aug-02-25 03:07AM	Fulgent Genetics Inc (FLGT) Q2 2025 Earnings Call Highlights: Strong Core Revenue Growth Amid ... (GuruFocus.com)
Aug-01-25 04:26PM	Why Fulgent Genetics Stock Was Crushing It on Friday (Motley Fool) +7.86%
08:10AM	Fulgent Genetics, Inc. (FLGT) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
07:00AM	Fulgent Reports Second Quarter 2025 Financial Results (Business Wire)
Jul-17-25 07:00AM	Fulgent Genetics Receives EU CE Mark for FulgentExome & FulgentPLM (Business Wire)
Jul-10-25 04:05PM	Fulgent to Announce Second Quarter 2025 Financial Results on Friday, August 1, 2025 (Business Wire)
May-19-25 08:11AM	Wolf Haldenstein Adler Freeman & Herz LLP is investigating Fulgent Genetics, Inc (PR Newswire)
May-03-25 03:03AM	Fulgent Genetics Inc (FLGT) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com)
May-02-25 11:35PM	Q1 2025 Fulgent Genetics Inc Earnings Call (Thomson Reuters StreetEvents) +19.07%
12:27PM	Fulgent Genetics, Inc. (FLGT) Q1 2025 Earnings Call Transcript (Seeking Alpha)
08:10AM	Loading…
08:10AM	Fulgent Genetics, Inc. (FLGT) Q1 Earnings and Revenues Beat Estimates (Zacks)
07:00AM	Fulgent Reports First Quarter 2025 Financial Results (Business Wire)
Apr-21-25 04:37PM	Fulgent Genetics Inc (FLGT) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com)
Apr-10-25 04:05PM	Fulgent to Announce First Quarter 2025 Financial Results on Friday, May 2, 2025 (Business Wire) +9.64%
Apr-04-25 02:30PM	Stock Picks From Seeking Alpha's March 2025 New Analysts (Seeking Alpha)
Mar-24-25 08:01AM	Hims & Hers Health (HIMS) Moves 5.7% Higher: Will This Strength Last? (Zacks)
Mar-20-25 05:46AM	Fulgent Genetics: Undervalued, CFO Buying, And Promising Drug Candidates Make It A Buy (SeekingAlpha)
Mar-07-25 06:19PM	DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600 (PR Newswire) -9.20%
Feb-28-25 11:30PM	Q4 2024 Fulgent Genetics Inc Earnings Call (Thomson Reuters StreetEvents)
08:10AM	Fulgent Genetics, Inc. (FLGT) Q4 Earnings and Revenues Beat Estimates (Zacks)
07:00AM	Fulgent Reports Fourth Quarter and Full Year 2024 Financial Results (Business Wire)
Feb-06-25 04:05PM	Fulgent to Announce Fourth Quarter and Full Year 2024 Financial Results on Friday, February 28, 2025 (Business Wire)
Dec-09-24 09:55AM	Wall Street Analysts Predict a 31.06% Upside in Fulgent Genetics (FLGT): Here's What You Should Know (Zacks)
Nov-22-24 12:00PM	All You Need to Know About Fulgent Genetics (FLGT) Rating Upgrade to Strong Buy (Zacks) +5.43%
Nov-19-24 07:16PM	Fulgent Genetics, Inc. (FLGT): Among the Best Genomics Stocks to Buy Right Now (Insider Monkey)
Nov-09-24 07:31AM	Fulgent Genetics Reports Strong Q3 2024 Results (TipRanks)
02:05AM	Fulgent Genetics Inc (FLGT) Q3 2024 Earnings Call Highlights: Strategic Growth Amid Revenue Decline (GuruFocus.com)
Nov-08-24 08:15AM	Fulgent Genetics, Inc. (FLGT) Surpasses Q3 Earnings and Revenue Estimates (Zacks) -11.76%
07:00AM	Fulgent Reports Third Quarter 2024 Financial Results (Business Wire)
Nov-05-24 08:00AM	Fulgent to Participate in Upcoming Conferences (Business Wire)
Nov-01-24 08:08AM	Fulgent Genetics (FLGT) Surges 5.8%: Is This an Indication of Further Gains? (Zacks)
Oct-31-24 08:00AM	Fulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans1 (Business Wire) +5.82%
Oct-17-24 04:05PM	Fulgent to Announce Third Quarter 2024 Financial Results on Friday, November 8, 2024 (Business Wire)
Aug-13-24 12:00PM	Fulgent Genetics (FLGT) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
09:55AM	How Much Upside is Left in Fulgent Genetics (FLGT)? Wall Street Analysts Think 27.22% (Zacks)
Aug-02-24 08:15AM	Fulgent Genetics, Inc. (FLGT) Beats Q2 Earnings and Revenue Estimates (Zacks) +6.32%
07:00AM	Fulgent Reports Second Quarter 2024 Financial Results (Business Wire)
Jul-18-24 04:36AM	Fulgent Genetics (FLGT) Soars 6.6%: Is Further Upside Left in the Stock? (Zacks) -5.53%
Jul-11-24 04:05PM	Fulgent to Announce Second Quarter 2024 Financial Results on Friday, August 2, 2024 (Business Wire) +5.41%
Jun-10-24 01:00AM	Press release Biocartis NV: Biocartis Welcomes Gina Wallar, PhD as Chief Business Officer and Judith Vacchino, PhD as VP Global Marketing (GlobeNewswire)
Jun-03-24 08:00AM	Fulgent Data at ASCO 2024 Highlights Antitumor Activity from Lead Therapeutic Oncology Candidate, FID-007, in Head and Neck Cancer (Business Wire)
May-24-24 08:00AM	Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual Meeting (Business Wire)
May-15-24 04:21AM	Moffitt and Fulgent Pharma partner on personalised cancer therapies (Pharmaceutical Technology)
May-14-24 04:05PM	Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer Therapeutics (Business Wire)
09:00AM	Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain (PR Newswire)
May-04-24 09:15AM	Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:04AM	Fulgent Genetics Inc (FLGT) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ... (GuruFocus.com)
May-03-24 10:46PM	Q1 2024 Fulgent Genetics Inc Earnings Call (Thomson Reuters StreetEvents)
11:53AM	FLGT Stock Earnings: Fulgent Genetics Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
08:34AM	Fulgent Genetics Inc (FLGT) Q1 2024 Earnings: Misses Analyst Forecasts with Wider Losses (GuruFocus.com)
08:15AM	Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
07:00AM	Fulgent Reports First Quarter 2024 Financial Results (Business Wire)
Apr-11-24 04:05PM	Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024 (Business Wire)
Feb-29-24 09:31AM	Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-28-24 10:18PM	Q4 2023 Fulgent Genetics Inc Earnings Call (Thomson Reuters StreetEvents) -8.14%
07:35AM	Fulgent Genetics Inc (FLGT) Faces GAAP Loss Despite Core Revenue Growth in 2023 (GuruFocus.com)
07:00AM	Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Feb-13-24 08:00AM	Fulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024 (Business Wire)
Feb-09-24 08:31AM	Cord Blood Registry (CBR) by CooperSurgical and Fulgent Genetics Launch Innovative Genetic Testing (PR Newswire)
Nov-25-23 09:45AM	The 3 Best Digital Health Stocks for Personalized Medicine (InvestorPlace)
Nov-14-23 04:30PM	Fulgent to Participate in the Piper Sandler 35th Annual Healthcare Conference (Business Wire)
Nov-05-23 09:02AM	Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-03-23 10:26PM	Q3 2023 Fulgent Genetics Inc Earnings Call (Thomson Reuters StreetEvents) +13.24%
04:05PM	Fulgent Shares Data from Two Poster Presentations at SITC 2023 Annual Meeting (Business Wire)
08:52AM	Fulgent Genetics Inc (FLGT) Reports Q3 2023 Financial Results (GuruFocus.com)
08:45AM	Fulgent Genetics, Inc. (FLGT) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
07:00AM	Fulgent Reports Third Quarter 2023 Financial Results (Business Wire)
Oct-30-23 03:46PM	Top 20 Genomics Companies in the World (Insider Monkey)
Oct-25-23 08:00AM	Fulgent Announces Two Poster Presentations at SITC 2023 Annual Meeting (Business Wire)
Oct-18-23 09:44AM	Strength Seen in Olink Holding AB (publ) Sponsored ADR (OLK): Can Its 66.0% Jump Turn into More Strength? (Zacks)
Oct-17-23 08:00AM	Fulgent Genetics to Announce Third Quarter 2023 Financial Results on Friday November 3, 2023 (Business Wire)
Aug-05-23 08:56AM	Fulgent Genetics, Inc. (NASDAQ:FLGT) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-04-23 10:08PM	Q2 2023 Fulgent Genetics Inc Earnings Call (Thomson Reuters StreetEvents) -12.82%
08:15AM	Fulgent Genetics, Inc. (FLGT) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:00AM	Fulgent Reports Second Quarter 2023 Financial Results (Business Wire)
Jul-24-23 04:05PM	Exagen Inc. Appoints Paul Kim to Board of Directors (GlobeNewswire)
Jul-18-23 08:00AM	Fulgent Genetics to Announce Second Quarter 2023 Financial Results on Friday, August 4, 2023 (Business Wire)
Jun-21-23 08:00PM	FLGT: Lowering target price to $29.00 (Argus Research)
Jun-14-23 11:40AM	10 DNA Stocks Billionaires Are Loading Up On (Insider Monkey)
Jun-06-23 07:45AM	Got $2,500? This Dirt Cheap Growth Stock Could Be Worth Buying Hand Over Fist (Motley Fool)

Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded by Ming Hsieh on May 13, 2016 and is headquartered in El Monte, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Xie Jian	President and COO	Dec 02 '25	Sale	28.33	1,140	32,298	336,749	Dec 03 05:04 PM
Gao Hanlin	Chief Scientific Officer	Dec 02 '25	Sale	28.33	1,075	30,457	952,890	Dec 03 05:04 PM
Xie Jian	President and COO	Nov 28 '25	Sale	29.57	1,198	35,424	337,889	Dec 01 09:14 PM
Gao Hanlin	Chief Scientific Officer	Nov 28 '25	Sale	29.57	943	27,884	953,965	Dec 01 09:14 PM
Gao Hanlin	Officer	Dec 02 '25	Proposed Sale	28.52	1,070	30,516		Dec 01 09:13 PM
Xie Jian	Officer	Dec 02 '25	Proposed Sale	28.52	1,135	32,370		Dec 01 09:12 PM
Xie Jian	Officer	Nov 28 '25	Proposed Sale	30.15	1,198	36,120		Nov 26 08:26 PM
Gao Hanlin	Officer	Nov 28 '25	Proposed Sale	30.15	943	28,431		Nov 26 08:24 PM
Xie Jian	President and COO	Nov 24 '25	Sale	30.47	681	20,752	339,087	Nov 25 04:30 PM
Gao Hanlin	Chief Scientific Officer	Nov 24 '25	Sale	30.47	535	16,303	954,908	Nov 25 04:30 PM
Xie Jian	Officer	Nov 24 '25	Proposed Sale	30.47	681	20,752		Nov 24 06:37 PM
Gao Hanlin	Officer	Nov 24 '25	Proposed Sale	30.47	535	16,303		Nov 24 06:36 PM
Xie Jian	President and COO	Nov 19 '25	Sale	29.10	10,000	290,983	349,768	Nov 21 04:30 PM
Xie Jian	Officer	Nov 19 '25	Proposed Sale	29.10	10,000	290,983		Nov 19 08:03 PM
Gao Hanlin	Chief Scientific Officer	Sep 03 '25	Sale	22.03	1,063	23,414	957,085	Sep 03 05:33 PM
Xie Jian	President and COO	Sep 03 '25	Sale	22.03	1,128	24,846	364,121	Sep 03 05:33 PM
Xie Jian	Officer	Sep 03 '25	Proposed Sale	22.03	1,128	24,846		Sep 03 05:29 PM
Gao Hanlin	Officer	Sep 03 '25	Proposed Sale	22.03	1,063	23,414		Sep 03 05:29 PM
Xie Jian	President and COO	Aug 27 '25	Sale	21.48	1,199	25,760	365,249	Aug 28 06:55 PM
Gao Hanlin	Chief Scientific Officer	Aug 27 '25	Sale	21.48	943	20,260	958,148	Aug 28 06:55 PM
Xie Jian	Officer	Aug 27 '25	Proposed Sale	21.48	1,199	25,760		Aug 27 07:49 PM
Gao Hanlin	Officer	Aug 27 '25	Proposed Sale	21.48	943	20,260		Aug 27 07:47 PM
Xie Jian	President and COO	Aug 25 '25	Sale	21.50	696	14,965	366,448	Aug 26 07:13 PM
Gao Hanlin	Chief Scientific Officer	Aug 25 '25	Sale	21.50	548	11,783	959,091	Aug 26 07:10 PM
Xie Jian	Officer	Aug 25 '25	Proposed Sale	21.50	696	14,965		Aug 25 08:24 PM
Gao Hanlin	Chief Scientific Officer	Jun 02 '25	Sale	20.29	754	15,299	961,281	Jun 03 04:47 PM
Xie Jian	President and COO	Jun 02 '25	Sale	20.29	1,135	23,030	371,496	Jun 03 04:46 PM
Xie Jian	Officer	Jun 02 '25	Proposed Sale	20.29	1,135	23,030		Jun 02 04:49 PM
Xie Jian	President and COO	May 27 '25	Sale	20.54	1,873	38,468	372,631	May 28 04:17 PM
Gao Hanlin	Chief Scientific Officer	May 27 '25	Sale	20.54	1,039	21,339	962,035	May 28 04:16 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

FLGT

Fulgent Genetics Inc

Upgrade your FINVIZ experience